News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
562,665 Results
Type
Article (32887)
Company Profile (93)
Press Release (529683)
Multimedia
Podcasts (131)
Webinars (17)
Section
Business (168189)
Career Advice (1805)
Deals (31904)
Drug Delivery (90)
Drug Development (58899)
Employer Resources (116)
FDA (12392)
Job Trends (11782)
News (276600)
Policy (24267)
Tag
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1914)
Academic (1)
Accelerated approval (20)
Adcomms (19)
Allergies (106)
Alliances (42561)
ALS (132)
Alzheimer's disease (1245)
Antibody-drug conjugate (ADC) (261)
Approvals (12697)
Artificial intelligence (480)
Autoimmune disease (127)
Automation (30)
Bankruptcy (247)
Best Places to Work (9267)
BIOSECURE Act (9)
Biosimilars (140)
Biotechnology (72)
Bladder cancer (138)
Brain cancer (49)
Breast cancer (509)
Cancer (3907)
Cardiovascular disease (335)
Career advice (1548)
Career pathing (32)
CAR-T (219)
CDC (28)
Cell therapy (617)
Cervical cancer (28)
Clinical research (50805)
Collaboration (1528)
Company closure (2)
Compensation (582)
Complete response letters (40)
COVID-19 (1911)
CRISPR (73)
C-suite (675)
Cystic fibrosis (108)
Data (5196)
Decentralized trials (2)
Denatured (41)
Depression (112)
Diabetes (410)
Diagnostics (5206)
Digital health (40)
Diversity (7)
Diversity, equity & inclusion (36)
Drug discovery (230)
Drug pricing (132)
Drug shortages (21)
Duchenne muscular dystrophy (178)
Earnings (75917)
Editorial (53)
Employer branding (14)
Employer resources (105)
Events (89452)
Executive appointments (814)
FDA (14924)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (19)
Funding (1162)
Gene editing (150)
Generative AI (49)
Gene therapy (495)
GLP-1 (784)
Government (3051)
Grass and pollen (6)
Guidances (364)
Healthcare (14504)
HIV (52)
Huntington's disease (29)
IgA nephropathy (67)
Immunology and inflammation (193)
Immuno-oncology (45)
Indications (97)
Infectious disease (2100)
Inflammatory bowel disease (155)
Inflation Reduction Act (12)
Influenza (88)
Intellectual property (190)
Interviews (314)
IPO (13380)
IRA (39)
Job creations (2886)
Job search strategy (1275)
JPM (64)
Kidney cancer (13)
Labor market (57)
Layoffs (406)
Leadership (32)
Legal (6451)
Liver cancer (70)
Longevity (10)
Lung cancer (537)
Lymphoma (306)
Machine learning (30)
Management (39)
Manufacturing (648)
MASH (143)
Medical device (10367)
Medtech (10409)
Mergers & acquisitions (19577)
Metabolic disorders (1018)
Multiple sclerosis (128)
NASH (13)
Neurodegenerative disease (250)
Neuropsychiatric disorders (74)
Neuroscience (2227)
Neurotech (1)
NextGen: Class of 2026 (4987)
Non-profit (3509)
Now hiring (12)
Obesity (459)
Opinion (238)
Ovarian cancer (121)
Pain (150)
Pancreatic cancer (172)
Parkinson's disease (227)
Partnered (28)
Patents (370)
Patient recruitment (347)
Peanut (38)
People (46869)
Pharmaceutical (25)
Pharmacy benefit managers (17)
Phase 1 (15170)
Phase 2 (21879)
Phase 3 (17701)
Pipeline (4627)
Policy (197)
Postmarket research (2143)
Preclinical (6547)
Press Release (72)
Prostate cancer (221)
Psychedelics (40)
Radiopharmaceuticals (241)
Rare diseases (681)
Real estate (4339)
Recruiting (46)
Regulatory (18136)
Reports (39)
Research institute (1851)
Resumes & cover letters (285)
Rett syndrome (26)
RNA editing (13)
RSV (51)
Schizophrenia (130)
Series A (202)
Series B (145)
Service/supplier (4)
Sickle cell disease (78)
Special edition (17)
Spinal muscular atrophy (125)
Sponsored (34)
Startups (2609)
State (1)
Stomach cancer (10)
Supply chain (79)
Tariffs (58)
The Weekly (89)
Vaccines (736)
Venture capital (69)
Weight loss (302)
Women's health (59)
Worklife (15)
Date
Today (95)
Last 7 days (507)
Last 30 days (1714)
Last 365 days (24879)
2026 (2894)
2025 (25167)
2024 (27933)
2023 (31203)
2022 (40701)
2021 (43655)
2020 (42332)
2019 (36298)
2018 (27466)
2017 (25618)
2016 (24893)
2015 (29515)
2014 (24337)
2013 (20798)
2012 (21510)
2011 (21640)
2010 (20742)
Location
Africa (683)
Alabama (69)
Alaska (5)
Arizona (205)
Arkansas (9)
Asia (31852)
Australia (5048)
California (8732)
Canada (2633)
China (874)
Colorado (367)
Connecticut (411)
Delaware (269)
Europe (71977)
Florida (1388)
Georgia (286)
Hawaii (2)
Idaho (46)
Illinois (652)
India (60)
Indiana (439)
Iowa (16)
Japan (395)
Kansas (99)
Kentucky (25)
Louisiana (18)
Maine (71)
Maryland (1033)
Massachusetts (6318)
Michigan (277)
Minnesota (446)
Mississippi (2)
Missouri (96)
Montana (27)
Nebraska (19)
Nevada (105)
New Hampshire (56)
New Jersey (3065)
New Mexico (19)
New York (2336)
North Carolina (1167)
North Dakota (6)
Northern California (4269)
Ohio (268)
Oklahoma (16)
Oregon (28)
Pennsylvania (1791)
Puerto Rico (18)
Rhode Island (36)
South America (967)
South Carolina (42)
Southern California (3417)
Tennessee (158)
Texas (1329)
United States (32004)
Utah (277)
Vermont (1)
Virginia (205)
Washington D.C. (58)
Washington State (744)
West Virginia (3)
Wisconsin (97)
Wyoming (2)
562,665 Results for "alza corporation acquired by j and j".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
J&J Aims for $100B in Sales, Puts Stelara Patent Cliff ‘in the Rearview Mirror’
Reporting Q4 and full year earnings on Wednesday, J&J executives hailed growth across the healthcare giant’s portfolio while standing fast on its talc lawsuit and tariffs.
January 21, 2026
·
2 min read
·
Dan Samorodnitsky
Immunology and inflammation
J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark
J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action could improve on existing therapies.
January 5, 2026
·
2 min read
·
Nick Paul Taylor
Artificial intelligence
J&J, Lilly Crest AI Wave With Nvidia Partnerships
Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to create the industry’s ‘most powerful supercomputer’ and J&J building a virtual operating room.
October 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bruker Corporation to Present at the J.P. Morgan Healthcare Conference
January 8, 2026
·
1 min read
Psychedelics
AbbVie CSO Touts ‘Breakthrough Type Therapy’ Psychedelic as J&J’s Spravato Keeps Growing
Sales of Johnson & Johnson’s esketamine-based nasal spray jumped in the fourth quarter last year, priming the pump for a suite of other pharmas, including AbbVie, champing at the bit with their own psychedelics.
February 6, 2026
·
2 min read
·
Dan Samorodnitsky
Cancer
J&J’s Darzalex Faspro Notches Another Multiple Myeloma Indication, Pushing Into Frontline
Darzalex Faspro, in combination with an anti-cancer triplet, is the first anti-CD38-based regimen for newly diagnosed patients with multiple myeloma, regardless of eligibility for stem cell transplantation.
January 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
January 22, 2026
·
4 min read
Manufacturing
J&J To Add 500 Jobs at New Plant, Doubling Down on North Carolina
Johnson & Johnson’s second facility in Wilson, North Carolina, is part of a $55 billion push to make all advanced medicines used in the U.S. domestically.
January 13, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Kardigan Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference and Provides Corporate Update for 2026
January 7, 2026
·
5 min read
Press Releases
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
December 19, 2025
·
1 min read
1 of 56,267
Next
